Rochester, NY – February 15, 2007 – iCardiac Technologies, Inc., a leader in the development and implementation of biomarkers and technologies for assessing the cardiac safety of pharmaceutical products, announced today that it has added three new members to its Board of Directors. Additionally, the University of Rochester Medical Center spin-off company announced that its Chief Executive Officer, Mikael Totterman, has been promoted and is taking on the additional role as the company’s Chairman of the Board.
